Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article
Open Access Highly Access

A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors

Dana Inbar-Rozensal, Asher Castiel, Leonid Visochek, David Castel, Françoise Dantzer, Shai Izraeli and Malka Cohen-Armon*

Breast Cancer Research 2009, 11:R78 doi:10.1186/bcr2445


See related editorial by Frizzell and Kraus, http://breast-cancer-research.com/content/11/6/111

Accesses  

  • Last 30 days: 82 accesses
  • Last 365 days: 1198 accesses
  • All time: 11512 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells

Asher Castiel, Leonid Visochek, Leonid Mittelman, Françoise Dantzer, Shai Izraeli, Malka Cohen-Armon BMC Cancer 2011, 11:412 (26 September 2011)

Abstract | Full text | PDF | PubMed

Editorial   Free Highly Accessed

PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

Kristine M Frizzell, W Lee Kraus Breast Cancer Research 2009, 11:111 (26 November 2009)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations